Oxford BioMedica (OXB) Reaches New 1-Year High at $11.98
Oxford BioMedica plc (LON:OXB)’s share price reached a new 52-week high on Tuesday . The company traded as high as GBX 11.98 ($0.16) and last traded at GBX 10.62 ($0.14), with a volume of 20060000 shares. The stock had previously closed at GBX 11.10 ($0.15).
Separately, Peel Hunt reissued a “buy” rating and issued a GBX 13 ($0.18) price target on shares of Oxford BioMedica in a report on Monday, January 8th.
In other Oxford BioMedica news, insider Lorenzo Tallarigo acquired 29,365 shares of the stock in a transaction dated Wednesday, December 20th. The stock was acquired at an average price of GBX 9 ($0.12) per share, with a total value of £2,642.85 ($3,584.01).
About Oxford BioMedica
Oxford BioMedica plc is a gene and cell therapy company. The Company is engaged in lentiviral vector and cell therapy research, development and production. The Company’s segments include Partnering, and R&D. The Partnering segment provides lentiviral vector bioprocessing and process development services to partners.
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.